Victoria's Secret & Co. just handed short sellers one of the most painful days in recent retail history — a 47% single-session surge to $80.06 that followed an earnings print, with the stock up 43% on the week and 53% on the month.
The setup could not have been more charged against the bears. As documented in the pre-earnings note published the same morning, short interest had ballooned 32% in a single month, climbing from roughly 10 million shares at end-April to 13 million by June 1, representing 16.2% of free float. With 6.4 days to cover and the lending market wide open — availability was running near 470%, meaning roughly five shares available for every one borrowed — shorts were in by choice, not trapped by a tight borrow. That choice is now looking very costly. Cost to borrow has already begun to respond, jumping 28% on the week to 0.55%, though it remains low in absolute terms. The more telling signal is that availability, at 459% today, has begun tightening off its recent highs near 563% in early May, suggesting incremental demand for borrows as the short thesis is reassessed — or defended.
The options market had been quietly flashing the other side of this trade for weeks. The put/call ratio, which ran between 0.77 and 0.83 through late April and early May, had been collapsing steadily — hitting 0.58 on June 1, below its 20-day average of 0.60. That shift from defensive to neutral/bullish options positioning preceded the print and now looks like early positioning by bulls who saw the earnings beat coming. The ORTEX short score has also been drifting lower all week, from 62.0 on May 20 to 60.6 by June 2 — not dramatic, but directionally consistent with a thesis coming under pressure before the stock moved.
The Street's reaction is now the central story. Heading into the print, analyst consensus was a fractured hold, with just three buys against four holds and a mean price target of $81 — which the stock has now essentially touched. Wells Fargo upgraded to Overweight with a $57 target in early May; Bank of America moved to Buy with a $68 target on April 29. Both targets have already been blown through. Barclays had cut its target to $67 in March after previously raising it to $80. The bull case — strong earnings beat, raised outlook, beauty category momentum, and renewed traction across brands and geographies — has played out. The bear case centred on tariff drag and declining bra sales has, at least for now, been overtaken by events. With consensus targets now sitting at or below the current price, the Street faces an immediate reckoning on where fair value sits.
Institutional positioning adds an interesting wrinkle. BlackRock holds 14.9% of shares, Brett Blundy (via BBRC International) 13.0%, and FMR LLC added 2.7 million shares in the most recent reporting period to reach 7.6%. Greenlight Capital added 519,000 shares as of March 31. The insider picture has been more mixed: CEO Hillary Super sold $1.1 million in March, and the CFO trimmed a small position in February, though the independent board chair made a modest purchase in April. The most significant insider activity remains the strategic accumulation by BBRC — which bought 796,500 shares across late March and early April 2025 at prices well below current levels — a position that has now more than quadrupled in value.
What to watch next: the earnings call scheduled for June 11 will be the first opportunity for management to frame how much of the raised outlook is already priced in, and whether the beauty and international momentum that drove the beat is structural or seasonal — the answer to that question will determine whether $80 is a ceiling or a floor for this re-rating.
See the live data behind this article on ORTEX.
Open VSXY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
